Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1433542
PUBLISHER: Grand View Research | PRODUCT CODE: 1433542
Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Type, By Drug, By Vaccine, By Route of Administration, By End-use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Herpes Simplex Virus Treatment Market Growth & Trends:
The global herpes simplex virus treatment market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.
According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.
Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.
Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth.
Herpes Simplex Virus Treatment Market Report Highlights:
- By treatment, the HSV-1 segment held the largest share in 2023 owing to the high prevalence of infection
- By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
- By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
- North America dominated the global market in 2023 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure
Product Code: GVR-4-68039-983-7
Table of Contents
Chapter 1 Herpes Simplex Virus Treatment Market: Methodology and Scope
- 1.1 Research Methodology
- 1.2 Research Assumptions
- 1.2.1 Estimates and Forecasts timeline
- 1.3 Information Procurement
- 1.3.1 Purchased database
- 1.3.2 GVR's internal database
- 1.3.3 Secondary sources
- 1.3.4 Primary research
- 1.3.5 Details of primary research
- 1.4 Information or Data Analysis
- 1.4.1 Data analysis models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity flow analysis
- 1.6.1.1 Approach 1: Commodity flow approach
- 1.6.2 Volume price analysis (model 2)
- 1.6.2.1 Approach 2: Volume price analysis
- 1.6.2.2 Revenue modeling
- 1.6.1 Commodity flow analysis
- 1.7 List of Secondary Sources
- 1.8 List of Primary Sources
Chapter 2 Herpes Simplex Virus Treatment Market: Executive Summary
- 2.1 Market Summary
Chapter 3 Herpes Simplex Virus Treatment Market: Industry Outlook
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.1.1 Growing prevalence of herpes infection
- 3.3.1.2 Development of novel treatment options
- 3.3.1.3 Increasing government funding
- 3.3.1.3 Technological advancements
- 3.3.2 Market Restraint Analysis
- 3.3.2.1 Unavailability of vaccine
- 3.3.1 Market Driver Analysis
- 3.4 Porter's Five Forces Analysis
- 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
- 3.6 Regulatory Framework
- 3.7 User Perspective Analysis
Chapter 4 Herpes Simplex Virus Treatment Market: Competitive Landscape
- 4.1 Recent developments & impact analysis, by key market participants
- 4.1.1 Ansoff Matrix
- 4.2 Major deals & strategic alliances analysis
- 4.2.1 Joint Ventures
- 4.2.2 Licensing and Partnerships
- 4.2.3 Technological Collaborations
- 4.3 Company/Competition Categorization
- 4.4 Vendor Landscape
- 4.4.1 List Of Key Distributors and Channel Partners
- 4.4.2 Key Customers
- 4.5 Public Companies
- 4.5.1 Company Market Position Analysis
- 4.6 Private Companies
- 4.6.1 List Of Key Emerging Companies
- 4.6.2 Regional Network Map
Chapter 5 Herpes Simplex Virus Treatment Market: Type Business Analysis
- 5.1 Definition and Scope
- 5.2 Type Market Share Analysis, 2023 & 2030
- 5.3 Global Herpes Simplex Virus Treatment Market, By Type, 2018 To 2030
- 5.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
- 5.4.1 Herpes Simplex Virus-1 (HSV-1)
- 5.4.1.1 Herpes Simplex Virus-1 (HSV-1) Market 2018 - 2030 (USD Million)
- 5.4.2 Herpes Simplex Virus-2 (HSV-2)
- 5.4.2.1 Herpes Simplex Virus-2 (HSV-2) Market, 2018 - 2030 (USD Million)
- 5.4.1 Herpes Simplex Virus-1 (HSV-1)
Chapter 6 Herpes Simplex Virus Treatment Market: Drug Business Analysis
- 6.1 Definition and Scope
- 6.2 Drug Market Share Analysis, 2023 & 2030
- 6.3 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 To 2030
- 6.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
- 6.4.1 Acyclovir
- 6.4.1.1 Acyclovir Market 2018 - 2030 (USD Million)
- 6.4.2 Valacyclovir
- 6.4.2.1 Valacyclovir Market, 2018 - 2030 (USD Million)
- 6.4.3 Famciclovir
- 6.4.3.1 Famciclovir Market, 2018 - 2030 (USD Million)
- 6.4.4 Other Drugs
- 6.4.4.1 Other Drugs Market, 2018 - 2030 (USD Million)
- 6.4.1 Acyclovir
Chapter 7 Herpes Simplex Virus Treatment Market: Vaccine Business Analysis
- 7.1 Definition and Scope
- 7.2 Vaccine Market Share Analysis, 2023 & 2030
- 7.3 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 To 2030
- 7.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
- 7.4.1 Simplirix
- 7.4.1.1 Simplirix Market 2018 - 2030 (USD Million)
- 7.4.2 Others
- 7.4.2.1 Others Market, 2018 - 2030 (USD Million)
- 7.4.1 Simplirix
Chapter 8 Herpes Simplex Virus Treatment Market: Route of Administration Business Analysis
- 8.1 Definition and Scope
- 8.2 Route of Administration Market Share Analysis, 2023 & 2030
- 8.3 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 To 2030
- 8.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
- 8.4.1 Oral
- 8.4.1.1 Oral Market 2018 - 2030 (USD Million)
- 8.4.2 Injectable
- 8.4.2.1 Injectable Market, 2018 - 2030 (USD Million)
- 8.4.3 Topical
- 8.4.3.1 Topical Market, 2018 - 2030 (USD Million)
- 8.4.1 Oral
Chapter 9 Herpes Simplex Virus Treatment Market: End-use Business Analysis
- 9.1 Definition and Scope
- 9.2 End-use Market Share Analysis, 2023 & 2030
- 9.3 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 To 2030
- 9.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
- 9.4.1 Hospital Pharmacy
- 9.4.1.1 Hospital Pharmacy Market 2018 - 2030 (USD Million)
- 9.4.2 Retail Pharmacy
- 9.4.2.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
- 9.4.3 Online Pharmacy
- 9.4.3.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
- 9.4.1 Hospital Pharmacy
Chapter 10 Herpes Simplex Virus Treatment Market: Regional Business Analysis
- 10.1 Definition & Scope
- 10.2 Regional Market Share Analysis, 2023 & 2030
- 10.3 Regional Market Dashboard
- 10.4 Regional Market Snapshot
- 10.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- 10.5.1 North America
- 10.5.2 Europe
- 10.5.3 Asia Pacific
- 10.5.4 Latin America
- 10.5.5 MEA
- 10.6 Market Size, & Forecasts, Trends Analysis, 2023 to 2030
- 10.7 North America
- 10.7.1 North America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.7.2 U.S.
- 10.7.2.1 U.S. Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.7.3 Canada
- 10.7.3.1 Canada Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8 Europe
- 10.8.1 Europe Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.2 UK
- 10.8.2.1 UK Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.3 Germany
- 10.8.3.1 Germany Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.4 France
- 10.8.4.1 France Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.5 Italy
- 10.8.5.1 Italy Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.6 Spain
- 10.8.6.1 Spain Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.7 Denmark
- 10.8.7.1 Denmark Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.8 Sweden
- 10.8.8.1 Sweden Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.8.9 Norway
- 10.8.9.1 Norway Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.9 Asia Pacific
- 10.9.1 Asia-Pacific Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.9.2 Japan
- 10.9.2.1 Japan Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.9.3 China
- 10.9.3.1 China Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.9.4 India
- 10.9.4.1 India Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.9.5 Australia
- 10.9.5.1 Australia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.9.6 South Korea
- 10.9.6.1 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.9.7 Thailand
- 10.9.7.1 Thailand Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.10 Latin America
- 10.10.1 Latin America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.10.2 Brazil
- 10.10.2.1 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.10.3 Mexico
- 10.10.3.1 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.10.4 Argentina
- 10.10.4.1 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.11 MEA
- 10.11.1 MEA Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.11.2 South Africa
- 10.11.2.1 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.11.3 Saudi Arabia
- 10.11.3.1 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.11.4 UAE
- 10.11.4.1 UAE Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
- 10.11.5 Kuwait
- 10.11.5.1 Kuwait Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
Chapter 11 Herpes Simplex Virus Treatment Market: Company Profiling
- 11.1 Company Profiles
- 11.1.1. GSK plc
- 11.1.1.1 Company Overview
- 11.1.1.2 Financial Performance
- 11.1.1.3 Product Benchmarking
- 11.1.1.4 Strategic Initiatives
- 11.1.2. Carlsbad Tech
- 11.1.2.1 Company Overview
- 11.1.2.2 Financial Performance
- 11.1.2.3 Product Benchmarking
- 11.1.2.4 Strategic Initiatives
- 11.1.3. Emcure Pharmaceuticals Ltd.,
- 11.1.3.1 Company Overview
- 11.1.3.2 Financial Performance
- 11.1.3.3 Product Benchmarking
- 11.1.3.4 Strategic Initiatives
- 11.1.4. Sanofi
- 11.1.4.1 Company Overview
- 11.1.4.2 Financial Performance
- 11.1.4.3 Product Benchmarking
- 11.1.4.4 Strategic Initiatives
- 11.1.5. Glenmark Pharmaceuticals Inc.
- 11.1.5.1 Company Overview
- 11.1.5.2 Financial Performance
- 11.1.5.3 Product Benchmarking
- 11.1.5.4 Strategic Initiatives
- 11.1.6. Fresenius Kabi AG
- 11.1.6.1 Company Overview
- 11.1.6.2 Financial Performance
- 11.1.6.3 Product Benchmarking
- 11.1.6.4 Strategic Initiatives
- 11.1.7. Apotex Inc.
- 11.1.7.1 Company Overview
- 11.1.7.2 Financial Performance
- 11.1.7.3 Product Benchmarking
- 11.1.7.4 Strategic Initiatives
- 11.1.8. Viatris Inc. (Mylan)
- 11.1.8.1 Company Overview
- 11.1.8.2 Financial Performance
- 11.1.8.3 Product Benchmarking
- 11.1.8.4 Strategic Initiatives
- 11.1.9 Teva Pharmaceuticals Industries Ltd.
- 11.1.11.1 Company Overview
- 11.1.9.2 Financial Performance
- 11.1.9.3 Product Benchmarking
- 11.1.9.4 Strategic Initiatives
- 11.1.1. GSK plc
Product Code: GVR-4-68039-983-7
List of Tables
- TABLE 1 List of Secondary Sources
- TABLE 2 List of Abbreviations
- TABLE 3 Regulatory Framework
- TABLE 4 Global Herpes Simplex Virus Treatment Market, By Region, 2018 - 2030 (USD Million)
- TABLE 5 Global Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 6 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 7 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 8 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 9 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 10 North America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
- TABLE 11 North America Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 12 North America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 13 North America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 14 North America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 15 North America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 16 U.S. Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 17 U.S. Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 18 U.S. Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 19 U.S. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 20 U.S. Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 21 Canada Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 22 Canada Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 23 Canada Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 24 Canada Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 25 Canada Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 26 Europe Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
- TABLE 27 Europe Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 28 Europe Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 29 Europe Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 30 Europe Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 31 Europe Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 32 UK Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 33 UK Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 34 UK Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 35 UK Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 36 UK Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 37 Germany Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 38 Germany Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 39 Germany Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 40 Germany Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 41 Germany Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 42 France Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 43 France Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 44 France Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 45 France Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 46 France Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 47 Spain Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 48 Spain Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 49 Spain Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 50 Spain Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 51 Spain Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 52 Italy Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 53 Italy Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 54 Italy Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 55 Italy Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 56 Italy Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 57 Denmark Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 58 Denmark Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 59 Denmark Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 60 Denmark Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 61 Denmark Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 62 Sweden Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 63 Sweden Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 64 Sweden Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 65 Sweden Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 66 Sweden Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 67 Norway Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 68 Norway Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 69 Norway Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 70 Norway Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 71 Norway Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 72 Asia Pacific Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
- TABLE 73 Asia Pacific Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 74 Asia Pacific Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 75 Asia Pacific Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 76 Asia Pacific Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 77 Asia Pacific Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 78 China Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 79 China Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 80 China Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 81 China Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 82 China Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 83 Japan Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 84 Japan Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 85 Japan Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 86 Japan Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 87 Japan Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 88 India Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 89 India Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 90 India Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 91 India Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 92 India Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 93 South Korea Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 94 South Korea Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 95 South Korea Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 96 South Korea Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 97 South Korea Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 98 Australia Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 99 Australia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 100 Australia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 101 Australia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 102 Australia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 103 Thailand Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 104 Thailand Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 105 Thailand Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 106 Thailand Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 107 Thailand Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 108 Latin America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
- TABLE 109 Latin America Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 110 Latin America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 111 Latin America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 112 Latin America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 113 Latin America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 114 Brazil Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 115 Brazil Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 116 Brazil Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 117 Brazil Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 118 Brazil Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 119 Mexico Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 120 Mexico Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 121 Mexico Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 122 Mexico Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 123 Mexico Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 124 Argentina Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 125 Argentina Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 126 Argentina Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 127 Argentina Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 128 Argentina Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 129 MEA Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
- TABLE 130 MEA Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 131 MEA Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 132 MEA Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 133 MEA Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 134 MEA Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 135 South Africa Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 136 South Africa Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 137 South Africa Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 138 South Africa Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 139 South Africa Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 140 Saudi Arabia Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 141 Saudi Arabia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 142 Saudi Arabia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 143 Saudi Arabia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 144 Saudi Arabia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 145 UAE Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 146 UAE Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 147 UAE Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 148 UAE Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 149 UAE Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
- TABLE 150 Kuwait Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
- TABLE 151 Kuwait Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
- TABLE 152 Kuwait Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
- TABLE 153 Kuwait Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
- TABLE 154 Kuwait Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
List of Figures
- FIG. 1 Market Research Process
- FIG. 2 Information Procurement
- FIG. 3 Primary Research Pattern
- FIG. 4 Market Research Approaches
- FIG. 5 Value Chain-Based Sizing & Forecasting
- FIG. 6 Market Formulation & Validation
- FIG. 7 Herpes Simplex Virus Treatment Market Segmentation
- FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
- FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
- FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
- FIG. 11 Penetration & Growth Prospect Mapping
- FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- FIG. 13 Porter's Five Forces Analysis
- FIG. 14 Market Penetration & Growth Prospect Mapping
- FIG. 15 Herpes Simplex Virus Treatment Market: Treatment Movement Analysis
- FIG. 16 Herpes Simplex Virus-1 (HSV-1)market, 2018 - 2030 (USD Million)
- FIG. 17 Herpes simplex virus-2 (HSV-2)market, 2018 - 2030 (USD Million)
- FIG. 18 Herpes Simplex Virus Treatment Market: Drug Movement Analysis
- FIG. 19 Acyclovir market, 2018 - 2030 (USD Million)
- FIG. 20 Valacyclovir market, 2018 - 2030 (USD Million)
- FIG. 21 Famciclovir market, 2018 - 2030 (USD Million)
- FIG. 22 Others drugs market, 2018 - 2030 (USD Million)
- FIG. 23 Herpes Simplex Virus Treatment Market: Vaccine Movement Analysis
- FIG. 24 Herpes Simplex Virus Treatment Market: Route of Administration Movement Analysis
- FIG. 25 Oral market, 2018 - 2030 (USD Million)
- FIG. 26 Injectable market, 2018 - 2030 (USD Million)
- FIG. 27 Topical market, 2018 - 2030 (USD Million)
- FIG. 28 Herpes Simplex Virus Treatment Market: End-use Movement Analysis
- FIG. 29 Hospital pharmacy market, 2018 - 2030 (USD Million)
- FIG. 30 Retail pharmacy market, 2018 - 2030 (USD Million)
- FIG. 31 Online pharmacy market, 2018 - 2030 (USD Million)
- FIG. 32 Regional Marketplace: Key Takeaways
- FIG. 33 Regional Outlook, 2018 & 2030
- FIG. 34 Regional Market Dashboard
- FIG. 35 Regional Market Place: Key Takeaways
- FIG. 36 North America, SWOT Analysis
- FIG. 37 Europe, SWOT Analysis
- FIG. 38 Asia Pacific, SWOT Analysis
- FIG. 39 Latin America, SWOT Analysis
- FIG. 40 MEA, SWOT Analysis
- FIG. 41 North America
- FIG. 42 North America Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 43 U.S. Key Country Dynamics
- FIG. 44 U.S. Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 45 Canada Key Country Dynamics
- FIG. 46 Canada Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 47 Europe
- FIG. 48 Europe Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 49 UK Key Country Dynamics
- FIG. 50 UK Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 51 Germany Key Country Dynamics
- FIG. 52 Germany Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 53 France Key Country Dynamics
- FIG. 54 France Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 55 Italy Key Country Dynamics
- FIG. 56 Italy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 57 Spain Key Country Dynamics
- FIG. 58 Spain Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 59 Denmark Key Country Dynamics
- FIG. 60 Denmark Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 61 Sweden Key Country Dynamics
- FIG. 62 Sweden Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 63 Norway Key Country Dynamics
- FIG. 64 Norway Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 65 Asia Pacific
- FIG. 66 Asia-Pacific Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 67 Japan Key Country Dynamics
- FIG. 68 Japan Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 69 China Key Country Dynamics
- FIG. 70 China Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 71 India Key Country Dynamics
- FIG. 72 India Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 73 Australia Key Country Dynamics
- FIG. 74 Australia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 75 South Korea Key Country Dynamics
- FIG. 76 South Korea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 77 Thailand Key Country Dynamics
- FIG. 78 Thailand Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 79 Latin America
- FIG. 80 Latin America Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 81 Brazil Key Country Dynamics
- FIG. 82 Brazil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 83 Mexico Key Country Dynamics
- FIG. 84 Mexico Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 85 Argentina Key Country Dynamics
- FIG. 86 Argentina Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 87 MEA
- FIG. 88 MEA Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 89 South Africa Key Country Dynamics
- FIG. 90 South Africa Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 91 Saudi Arabia Key Country Dynamics
- FIG. 92 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 93 UAE Key Country Dynamics
- FIG. 94 UAE Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 95 Kuwait Key Country Dynamics
- FIG. 96 Kuwait Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- FIG. 97 Strategy Mapping
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.